why choose us

First received: May 18, 2023

Clinical Trial: A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lupus Erythematosus, Systemic

Study Type: INTERVENTIONAL


Official Title: A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE CLINICAL EFFECT, PHARMACODYNAMIC, PHARMACOKINETIC AND SAFETY PROFILE OF PF-06823859 IN ADULT PARTICIPANTS WIT

Brief Summary: The purpose of this study is to learn about the effects, safety and how PF-06823859 is processed in adults with cutaneous lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) showing some skin symptoms.This study is seeking for participants who:are adults of 18 years of age or older.are confirmed to have CLE or SLE with some symptoms of the skin.have a cutaneous LE disease area and severity index activity (CLASI-A) score at least 8.About 48 participants will be selected to receive active study medicine…

Read more